Hannah Luna Hagemeyer

Early career Clinician Scientist

Hannah Luna Hagemeyer studied medicine at the Universities of Hamburg, Bern, Cape Town, and La Laguna and started her residency at the Department of Neurology at the University Medical Center Hamburg-Eppendorf (UKE) in 2025. After her doctoral thesis at the Institute of Neuroimmunology and Multiple Sclerosis (INIMS) about the interferon-stimulated gene Apolipoprotein L6 in viral and autoimmune neuroinflammation, she is currently investigating the dysregulated interferon cascade during neuroinflammation.

Hannah`s overarching goal within the FOR 5705 NeuroFlame is to identify neuronal stressors early in the interferon signaling pathway as therapeutic targets to alleviate neuroinflammatory diseases, such as multiple sclerosis. The key challenge in neuroinflammation addressed in this project is to differentiate between an adequate neuroprotective response and the uncontrolled, destructive inflammation.

Publications

Zonulin as Gatekeeper in Gut-Brain Axis: Dysregulation in Glioblastoma. Hagemeyer H., Hellwinkel O.J.C. & Plata-Bello J. Biomedicines. 12, 1649 (2024).

Early career scientists

Neuroflame is dedicated to promote early career scientists allowing them to establish their own independent line of research.

Maria Andres-Alonso

Medical Scientist

Hannah Luna Hagemeyer

Clinician Scientist

Francesco Laserra

Clinician Scientist